指南与共识免疫规划

乙型肝炎疫苗:世界卫生组织立场文件,2017年7月——建议

Hepatitis B vaccines: WHO position paper, July 2017 - Recommendations.
指南 / 共识 · Vaccine · 2017-07-22

本文摘录世界卫生组织(WHO)2017年7月乙型肝炎疫苗立场文件中的建议,该文件替代2009年5月版。建议涉及疫苗接种目标人群和适宜程序,强调所有婴儿出生时接种疫苗是预防乙型肝炎病毒相关疾病最有效的干预措施。建议经2016年10月免疫策略咨询专家组(SAGE)讨论。

要点

  • 所有婴儿出生时接种乙型肝炎疫苗是预防乙型肝炎病毒相关疾病最有效的干预措施。
  • 建议涉及乙型肝炎疫苗接种的目标人群和适宜接种程序。
  • 该立场文件替代2009年5月WHO乙型肝炎疫苗立场文件。

核心结论

  • 所有婴儿出生时接种疫苗是预防乙型肝炎病毒相关疾病最有效的干预措施。

研究设计与样本

  • 世界卫生组织(WHO)立场文件,建议经免疫策略咨询专家组(SAGE)于2016年10月讨论。

主要发现

  • 立场文件提供乙型肝炎疫苗及其储存、运输和部署的更新信息。

关键数值与推荐

  • 建议涉及乙型肝炎疫苗接种的目标人群和适宜接种程序。
  • 强调所有婴儿出生时接种疫苗是预防乙型肝炎病毒相关疾病最有效的干预措施。

临床怎么用

  • WHO发布立场文件为成员国提供卫生政策指导,主要涉及大规模免疫规划中疫苗的使用。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This article presents the World Health Organization's (WHO) recommendations on the use of hepatitis B vaccines excerpted from the Hepatitis B vaccines: WHO position paper, July 2017, published in the Weekly Epidemiological Record (Hepatitis B vaccines, 2017) [1]. This position paper replaces the May 2009 WHO position paper on hepatitis B vaccines (Hepatitis B vaccines, 2009) [2]. The position paper gives updated information on hepatitis B vaccines and their storage, transport and deployment. The recommendations concern the target groups for vaccination and the appropriate schedules. In particular, the recommendations stress the importance of vaccination of all infants at birth as the most effective intervention for the prevention of hepatitis B virus-associated disease worldwide. Footnotes to this paper provide a number of core references including references to grading tables that assess the quality of the scientific evidence, and to the evidence-to-recommendation table. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. Recommendations on the use of hepatitis B vaccines were discussed by SAGE in October 2016; evidence presented at these meetings can be accessed at: http://www.who.int/immunization/sage/meetings/2016/October/presentations_background_docs/en/.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. World Health Organization. Hepatitis B vaccines: WHO position paper, July 2017 - Recommendations. Vaccine. 2017. PMID: 28743487. doi:10.1016/j.vaccine.2017.07.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。